DNA diagnosis and the emergence of cancer genetic services in European health care

European Journal of Human Genetics

Volumn 5, Issue SUPPL. 2, 1997, Pages 25-30

  Stemerding, D ^a   Koch, L ^b   Bourret, P ^c,d,e  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d INSERM   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER; CANCER GENETICS; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; DNA DETERMINATION; EUROPE; FAMILIAL CANCER; GENETIC SCREENING; HEALTH CARE; HUMAN; MOLECULAR GENETICS; OVARY CANCER; PRIORITY JOURNAL;

EID: 0031454369     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1159/000484831     Document Type: Conference Paper

References (52)

1. Grody WW: The coming era of cancer genetic screening. Diagn Mol Pathol 1994;3:145-146.
2. Nowak R: Genetic testing set for takeoff. Science 1994;265:464-467.
3. Smith O: Genetic testing: Out of the bottle. Nat Med 1996;2:613-614.
4. Harris R, Harris H (eds): Genetics in Primary Care: Workshop of EC Concerted Action on Genetics Services in Europe. Central Manchester Healthcare Trust, 1995, pp 4-6.
5. Julian-Reynier C, et al: L'émergence sociale des consultations de génétique pour l'adulte. Vers une colonisation génétique de la médecine? Sociol Soc 1996, pp 28.
6. Koch L, Stemerding D: The sociology of entrenchment: A cystic fibrosis test for everyone? Soc Sci Med 1994;39:1211-1220.
7. Rip A: Introduction of new technology: Making use of recent insights from sociology and economics of technology. Technol Anal Strat Manage 1995;7:417-431.
8. Vasen HFA, et al: The value of screening and central registration of families with familial adenomatous polyposis: A study of 82 families in The Netherlands. Dis Colon Rectum 1990;33: 227-230.
9. Bulow S, Sondergaard JO, Moesgaard F: Familiår adenomatos polypose. Ugeskr Lager 1990;152:2628-2632.
10. Bulow S, Myrhoj T: Arvelig kolorektal cancer. Ugeskr Lager 1996;158:2959.
11. Thomson JPS: Leeds Castle Polyposis Group Meeting. Dis Colon Rectum 1988;31:613-616.
12. Bodmer WF, et al: Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-616.
13. Tops GMJ, et al: Presymptomatic diagnosis of familial adenomatous polyposis by bridging DNA markers. Lancet 1989;ii:1361-1363.
14. Houlston RS, et al: Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ 1990;301: 366-368.
15. Gorden J, et al: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
16. Kinzler KW, et al: Identification of FAP locus genes from chromosome 5q21. Science 1991; 253:661-665.
17. Nishisho I, et al: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253:665-669.
18. Vasen HFA, Muller HJ: DNA-onderzoek in families met erfelijke vormen van kanker. Ned Tijdschr Geneeskd 1991;135:1620-1623.
19. Vasen HFA, et al: Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996;348:433-435.
20. Lips CJM, et al: De ontdekking van genen verantwoordelijk voor erfelijke tumorsyndromen; klinische en maatschappelijke gevolgen. Ned Tijdschr Geneeskd 1994;138:60-63.
21. Vasen HFA, Devilee P: Periodiek onderzoek van families met een erfelijke predispositie voor mammacarcinoom. Ned Tijdschr Geneeskd 1993; 137:2350-2354.
22. Hall JM, et al: Linkage of early onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-1649.
23. Easton DF, Bishop DT, Ford D, Crockford GP: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 1993;52:678-701.
24. Miki Y, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
25. Wooster R, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-2090.
26. Wooster R, et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-792.
27. King M-C: Breast cancer genes: How many, where and who are they? Nat Genet 1992;2:89-90
28. Roberts L: Zeroing in on a breast cancer susceptibility gene. Science 1993;259:622-625.
29. Shattuck-Eidens D, et al: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 1995;273:535-541.
30. Plummer SJ, Casey G: Are we any closer to testing for common malignancies? Nat Med 1996;2:156-158.
31. Collins FS: BRCA1 - lots of mutations, lots of dilemmas. N Engl J Med 1996;334:186-188.
32. King M-C, Rowell S, Love SM: Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 1993;269:1975-1980.
33. Vasen HFA et al: Clinical heterogeneity of hereditary breast cancer and its impact on screening protocols: The Dutch experience on 24 families under surveillance. Eur J Cancer 1993;29A:1111-1114.
34. Hoskins KF, et al: Assessment and counselling for women with a family history of breast cancer: A guide for clinicians. JAMA 1995;273: 577-585.
35. Nowak R: Breast cancer gene offers surprises. Science 1994;265:1796-1799.
36. Friend SH: Breast cancer susceptibility testing: Realities in the post-genomic era. Nat Genet 1996;13:16-17.
37. Hubbard R, Lewontin RC: Pitfalls of genetic testing. N Engl J Med 1996;334:1192-1193.
38. Biesecker BB, et al: Genetic counselling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993;269:1970-1974.
39. National Advisory Council for Human Genome Research: Statement on the use of DNA testing for presymptomatic identification of cancer risk. JAMA 1994;271:785.
40. Kommission fur Öffentlichkeitsarbeit ethische Fragen der Gesellschaft für Humangenetik. Stellungnahme zur Entdeckung des Brustkrebsgens BRCA1. Med Genet 1995;7:8-10.
41. Statement of American Society of Clinical Oncology: Genetic testing for cancer susceptibility.J Clin Oncol 1996;14:1730-1796.
42. Cotton P: Prognosis, diagnosis or who knows? Time to learn what gene tests mean. JAMA 1995;273:93-95.
43. Wadman M: Panel softens cancer gene test warning. Nature 1996;380:573.
44. Geller G, et al: Genetic testing for susceptibility to adult-onset cancer: The process and content of informed consent. JAMA 1997;277: 1467-1474.
45. Ponder M, Green JM: BRCA1 testing: Some issues in moving from research to service. Psychooncology 1996;5:223-232.
46. Julian-Reynier C, et al: Risk perception, anxiety and attitudes toward predictive testing after cancer genetic consultations. Am J Hum Genet 1995;57:A296.
47. Niermeijer MF: Medical genetics and primary care in The Netherlands; in Harris R, Harris H (eds): Genetics in Primary Care: Workshop of EC Concerted Action on Genetics Services in Europe. Central Manchester Healthcare NHS Trust, 1995, pp 15-18.
48. Coghlan A: Hopelessness is key result of gene test. New Sci 1996;152(14 Sep):8.
49. Nelson NJ: Caution guides genetic testing for hereditary cancer genes. J Nat Cancer Inst 1996;88:70-72.
50. Armstrong D: The rise of surveillance medicine. Sociol Health Illness 1995;17:393-404.
51. Nederlandse Gezondheidsraad (Dutch Health Council). Genetische screening. Den Haag, 1994.
52. World Health Organisation: Guidelines on Ethical Issues in Medical Genetics and the Provision of Genetic Services (draft). Geneva, WHO, 1995.